Home · Products · Semax 15 mg pen

Pre-filled peptide pen

Semax 15 mg peptide pen

The ACTH-fragment nootropic-track compound at fifteen milligrams, injectable, while most of its home literature ran through the nose, as its spray twin acknowledges.

€ 95incl. VAT

In stock · dispatched within 24 h

Add to basket Request the COA

ISO-certified laboratory
COA per batch, ≥99% HPLC
Discreet dispatch within 24 h
Research use only

FormatFilled pen, peptide dissolved

Content15 mg

Purity≥ 99% (HPLC)

SKUPOL-SEMAX-PEPTIDE-PEN-15MG

This product

The cognition half, needle edition

Semax takes four residues of ACTH, stripped of hormonal activity, and adds the Pro-Gly-Pro tail that keeps the fragment alive long enough to study. Its BDNF-linked literature and Russian registration are covered honestly on the semax compound page; neither crosses into Western approval.

This pen exists for protocols that want delivery certainty over route tradition: most published semax work used the nasal route, and researchers replicating it usually want the spray instead. Both formats, one catalogue.

Compound	Semax
Content	15 mg, pre-filled
Derived from	ACTH 4–7 + PGP tail
Purity	≥ 99% (HPLC)
Regulatory status	Registered in Russia only
Twin format	Nasal spray, 10 mg/15 ml
Category	Research use only

Replicating published protocols? Check their route first, most used the spray.

Handling

Before the Semax 15 mg peptide pen reaches the bench

Standard pen care; the compound asks nothing special.

Using a peptide penThe dial, the cartridge and the habits that protect both Storage and shelf lifeRefrigerated after first use, dated, never frozen Pen vs vialWhy this compound ships pre-filled, and when a vial wins

Across weeks

One protocol, many sessions, held steady

A cognition series is only as clean as its least consistent session.

Cognition-track work rewards the same input repeated cleanly across weeks, which is where the pen format earns its place. Researchers who buy semax pen stock for a new protocol are choosing subcutaneous delivery certainty over the nasal route most published work used, a trade the compound page spells out. The advantage on the bench is the fixed click, the mechanism the pen handling page walks through: fifteen milligrams sit pre-dissolved, each increment matches the last, and no reconstitution step lets the quantity wander between sessions. For a multi-week series chasing a subtle BDNF-linked signal, that constancy is the backbone.

The habit that completes the discipline is documentary. Tie every session to the lot number on the pen, so a fortnight of cognition measurements all trace to one fifteen-milligram cartridge rather than a mix of batches. A single pen comfortably spans a typical multi-week run, which means the material is not the variable under test, the protocol is. Keep the route constant too: switching between the subcutaneous pen and the nasal format mid-series changes pharmacokinetics and quietly breaks the comparison, so route is fixed once and held.

The record

What the record backs, and where it stops

The interesting part of the semax file and the unproven part sit closer together than the enthusiasm admits.

Semax is more studied than most of this shelf and still far from settled. The ACTH four-to-seven fragment, stripped of adrenal signalling and stabilised by its Pro-Gly-Pro tail, has a genuine literature linking it to BDNF and neuroprotective endpoints, retrievable through the semax search on PubMed, but that literature is largely Russian-language, mostly preclinical or small-scale, and built around the nasal route rather than injection. Reading it honestly means holding two facts at once: the mechanism is real and interesting, and the weight of controlled human evidence a Western reviewer would demand simply is not there yet.

That last point lands with extra force here, because it is the pen. Most of the evidence a researcher would cite was generated through the nose, so carrying those findings onto a subcutaneous protocol adds an assumption the data has not directly checked. The Russian registration, likewise, means a real regulatory dossier exists under a different system and standard, not that any Western body has reviewed the compound. None of this makes the pen useless as apparatus; it just sets the terms for using it honestly.

Often ordered together

Twin and sibling

The route most of the literature used, and the anxiolytic-track sibling.

Coming soon≥99%

Cognition

Semax Nasal Spray

10 mg · nasal spray

€185incl. VAT

Not yet available, we are working hard on this format.

View the Semax pen

≥99%

Cognition

Selank Peptide Pen

15 mg · peptide pen

€95incl. VAT

Add to basket

Read first

The science behind Semax

The fragment, the sibling, the route call.

Compound

What is semax?

ACTH minus the hormone, plus the tail.

Read Area

Cognition research

The shelf this compound headlines.

Read Format

Nasal spray vs injection

Why route choice is protocol choice here.

Read

Questions

Questions about the Semax 15 mg peptide pen

For the cognition shelf’s lead compound.

Why buy the pen if the studies used sprays?

Delivery certainty: subcutaneous administration removes the mucosal variability the spray accepts, the route comparison page weighs both sides. Replication work wants the spray; new-protocol work often prefers the pen.

Does semax act like ACTH hormonally?

No, the fragment was chosen precisely because it drops the adrenal signalling while keeping the neuroactive interest. That separation is the design.

What does the Russian registration mean for me?

That a real regulatory dossier exists somewhere, under a different system, in a different language, to different standards. Our page reads it as context, not as approval.

Will one 15 mg pen last a full protocol?

For a typical multi-week cognition run, comfortably. The point is continuity: one cartridge keeps every session on the same lot, so nothing about the material shifts underneath your measurements. The fixed click holds each administration identical, so the protocol is the only variable. Exact amounts stay a study-design question, not this page’s.

How strong is the evidence for semax, really?

Genuine but qualified. The BDNF-linked, neuroprotective literature is real, yet largely Russian-language, mostly preclinical, and built on the nasal route rather than injection. Treat the mechanism as interesting and the controlled human case as unfinished, and note that nasal-route findings carried to this pen add an assumption of their own.

Ready to order?

Semax 15 mg pen, straight into your basket

Basket and card payment through Stripe; the batch certificate for Semax travels by email whenever you want it.

Add to basket Request the COA first

For laboratory and research use only. Not for human or animal consumption. Not a medicine and not a food supplement. Sold to persons aged 18 and over.